Slide 36 of 36
In conclusion, I will briefly relate the roundtable questions to our white paper:
- Dermal exposure assessment is important and needs further development.
- More comprehensive evaluation of cumulative exposures could become an IH priority by incorporating it into our study design recommendations.
- IHs would have better guidance for evaluating substances without OELs if there were a toxicity assessment protocol to follow and if there were more predictive models.
- Improved education and communication skills would help IHs to answer the questions posed by workers and managers.
- Future IH reports and codifying IH should be influenced by the development of various study design and monitoring method guidelines, and by the creation of an NOEDB.
- And finally, our team did not try to define any specific roles of individuals and organizations for bringing about new approaches and practices, but we do emphasize that the changes be effected by collaboration between government, industry, labor, and academia.